Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7869)
All Articles published online
|
Publishing Process of This Article
|
Apr 18, 2015 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bansal S, Singal AK, McGuire BM, Anand BS. Impact of all oral anti-hepatitis C virus therapy: A meta-analysis. World J Hepatol 2015; 7(5): 806-813 [PMID: 25914781 DOI: 10.4254/wjh.v7.i5.806] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i5/806.htm |
| Number | Citing Articles |
| 1 |
Shih Yea Sylvia Wu, Bridget Faire, Edward Gane. Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction. Case Reports in Medicine 2017; 2017: 1 doi: 10.1155/2017/4895736
|
| 2 |
Danyu Ye, Zhengyi Bao, Yang Yu, Zhenbo Han, Ying Yu, Zihang Xu, Wenya Ma, Ye Yuan, Lai Zhang, Yan Xu, Tianshuai Ma, Shenzhen Liu, Xinlu Gao, Gege Yan, Qi Huang, Xiuxiu Wang, Bingjie Hua, Fan Yang, Yuan Li, Benzhi Cai. Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity. Toxicology 2020; 435: 152422 doi: 10.1016/j.tox.2020.152422
|
| 3 |
Ashwani K. Singal, Patrick S. Kamath. Textbook of Liver Transplantation. 2022; : 121 doi: 10.1007/978-3-030-82930-8_9
|
| 4 |
Karin Hepp Schwambach, Mareni Rocha Farias, Giácomo Balbinotto Neto, Carine Raquel Blatt. Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data. Value in Health Regional Issues 2020; 23: 49 doi: 10.1016/j.vhri.2020.05.002
|
| 5 |
Saikiran M Kilaru, Ira M Jacobson. Sofosbuvir/velpatasvir/voxilaprevir in the Treatment of Chronic Hepatitis C Infection. Future Virology 2019; 14(2): 61 doi: 10.2217/fvl-2018-0134
|
| 6 |
Jorge Mera, Claudia Vellozzi, Susan Hariri, Hélène Carabin, Douglas A. Drevets, Anna Miller, Brigg Reilley, Whitney Essex, David Gahn, Lisa Lyons, Jessica Leston, John W. Ward. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection — Cherokee Nation, 2012–2015. MMWR. Morbidity and Mortality Weekly Report 2016; 65(18): 461 doi: 10.15585/mmwr.mm6518a2
|
| 7 |
Andrew H Talal, Emily O Dumas, Barbara Bauer, Richard M Rejman, Andrew Ocque, Gene D Morse, Danijela Lucic, Gavin A Cloherty, Jennifer King, Jiuhong Zha, Hongtao Zhang, Daniel E Cohen, Nancy Shulman, Jean-Michel Pawlotsky, Christophe Hézode. Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage. The Journal of Infectious Diseases 2018; 217(3): 474 doi: 10.1093/infdis/jix495
|
| 8 |
Grace Y. Zhang, Krupa Patel, Olufunso Agbalajobi, Wheytnie Alexandre, Andrea Reid, Marina Serper, Linda Calgaro, Susan Zickmund, Tami Coppler, Margaret Mizah, Obaid Shaikh, Shari Rogal. Patient perceptions of successful hepatitis C virus treatment adherence in Veterans. GastroHep 2021; 3(5): 307 doi: 10.1002/ygh2.474
|
| 9 |
Thanthima Suwanthawornkul, Thunyarat Anothaisintawee, Abhasnee Sobhonslidsuk, Ammarin Thakkinstian, Yot Teerawattananon, Ravi Jhaveri. Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis. PLOS ONE 2015; 10(12): e0145953 doi: 10.1371/journal.pone.0145953
|
| 10 |
Myron John Tong, Patrick Weijen Chang, Thatcher Thi Huynh, Alexander Anthony Rosinski, Lori Terese Tong. Adverse events associated with ribavirin in sofosbuvir‐based therapies for patients with chronic hepatitis C: A community practice experience. Journal of Digestive Diseases 2016; 17(2): 113 doi: 10.1111/1751-2980.12313
|
| 11 |
Mustafa S Ascha, Mona L Ascha, Ibrahim A Hanouneh. Management of immunosuppressant agents following liver transplantation: Less is more. World Journal of Hepatology 2016; 8(3): 148-161 doi: 10.4254/wjh.v8.i3.148
|
| 12 |
Ke Zheng, Si-zhi Wu, Yi-wen Lv, Peng Pang, Li Deng, Hua-chong Xu, Yu-cong Shi, Xiao-yin Chen. Carvacrol inhibits the excessive immune response induced by influenza virus A via suppressing viral replication and TLR/RLR pattern recognition. Journal of Ethnopharmacology 2021; 268: 113555 doi: 10.1016/j.jep.2020.113555
|
| 13 |
John Davison, Amy O’Shea, Nancee Waterbury, Yolanda Villalvazo. Examining Hepatitis, A and B Vaccination, and HBV Reactivation Monitoring During Direct-Acting Antiviral Therapy for Hepatitis C. Journal of Community Health 2018; 43(6): 1124 doi: 10.1007/s10900-018-0530-0
|
| 14 |
Rodolfo Castro, Hugo Perazzo, Beatriz Grinsztejn, Valdilea G. Veloso, Chris Hyde. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. International Journal of Hepatology 2015; 2015: 1 doi: 10.1155/2015/852968
|
| 15 |
Rowan Ahmed, Roaa Kareem, Nanditha Venkatesan, Rinky A Botleroo, Opemipo D Ogeyingbo, Renu Bhandari, Mallika Gyawali, Abeer O Elshaikh. Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection. Cureus 2021; doi: 10.7759/cureus.17237
|
| 16 |
Juan F. Yepes. The ADA Practical Guide to Patients with Medical Conditions. 2015; : 121 doi: 10.1002/9781119121039.ch6
|
| 17 |
Angus W Jeffrey, Yi Huang, W Bastiaan de Boer, Leon A Adams, Gerry MacQuillan, David Speers, John Joseph, Gary P Jeffrey. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World Journal of Hepatology 2017; 9(19): 850-856 doi: 10.4254/wjh.v9.i19.850
|
| 18 |
Jean-Baptiste Trabut, Camille Barrault, Hélène Charlot, Damien Carmona, Anne Bourdel, Mustapha Benslimane, Murielle François, Willy Kini-Matondo, Richard Causse, Françoise Roudot-Thoraval, Christophe Hézode. Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder. Journal of Addiction Medicine 2018; 12(5): 346 doi: 10.1097/ADM.0000000000000415
|
| 19 |
Rachel Webster, Miranda S. Moore, Angelica Bocour, Nirah Johnson, Ann Winters. Health Department Efforts to Increase Hepatitis C RNA Testing Among People Appearing Out of Care: Comparison of Outreach Approaches, New York City, 2017. Public Health Reports® 2020; 135(6): 823 doi: 10.1177/0033354920952068
|
| 20 |
Miranda S. Moore, Angelica Bocour, Fabienne Laraque, Ann Winters. A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017. Public Health Reports® 2018; 133(4): 497 doi: 10.1177/0033354918776641
|
| 21 |
Thidarath Rattanaburee, Mutita Junking, Aussara Panya, Nunghathai Sawasdee, Pucharee Songprakhon, Aroonroong Suttitheptumrong, Thawornchai Limjindaporn, Guy Haegeman, Pa-thai Yenchitsomanus. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A. Antiviral Research 2015; 124: 83 doi: 10.1016/j.antiviral.2015.10.005
|
| 22 |
Coralie Hermetet, Frederic Dubois, Catherine Gaudy-Graffin, Yannick Bacq, Bernard Royer, Christophe Gaborit, Louis D’Alteroche, Jean Claude Desenclos, Philippe Roingeard, Leslie Grammatico-Guillon, Yury E. Khudyakov. Continuum of hepatitis C care in France: A 20-year cohort study. PLOS ONE 2017; 12(8): e0183232 doi: 10.1371/journal.pone.0183232
|
| 23 |
Karin Hepp Schwambach, Carine Raquel Blatt. Effectiveness and potential drug interactions in antiviral therapy for the treatment of chronic hepatitis C: real-life data from a specialized center in southern Brazil. Brazilian Journal of Pharmaceutical Sciences 2021; 57 doi: 10.1590/s2175-9790201900041874
|
| 24 |
Ekta Gupta, Pragya Agarwala, Guresh Kumar, Rakhi Maiwall, Shiv Kumar Sarin. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. Journal of Clinical Virology 2017; 88: 46 doi: 10.1016/j.jcv.2017.01.006
|
| 25 |
Bassem Refaat, Adel Galal El-Shemi, Ahmed Mohamed Ashshi, Elaf Wael Mahamid, Noha Mohammed Al-Qadi, Limin Chen. Pegylated Interferon‐α Modulates Liver Concentrations of Activin‐A and Its Related Proteins in Normal Wistar Rat. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/414207
|
| 26 |
Ryo Iketani, Kazuki Ide, Hiroshi Yamada, Yohei Kawasaki, Naohiko Masaki. The Safety Profile of Telaprevir-Based Triple Therapy in Clinical Practice: A Retrospective Cohort Study. Biological & Pharmaceutical Bulletin 2017; 40(5): 687 doi: 10.1248/bpb.b16-00989
|
| 27 |
Shivank Madan, Snehal R. Patel, Kusha Rahgozar, Omar Saeed, Sandhya Murthy, Sasa Vukelic, Daniel B. Sims, Jooyoung Julia Shin, Daniel J. Goldstein, Ulrich P. Jorde. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era. The Journal of Heart and Lung Transplantation 2019; 38(9): 907 doi: 10.1016/j.healun.2019.06.023
|
| 28 |
Lingyao Du, Hong Tang. miRNA Antagonism and direct-acting Antivirals: Could This Be a Novel Combination Treatment Against HCV?. Future Virology 2016; 11(12): 753 doi: 10.2217/fvl-2016-0109
|
| 29 |
Naganori Kamiyama, Ryusuke Soma, Shinya Hidano, Kei Watanabe, Hiroshi Umekita, Chiaki Fukuda, Kaori Noguchi, Yoshiko Gendo, Takashi Ozaki, Akira Sonoda, Nozomi Sachi, Lucky Ronald Runtuwene, Yumako Miura, Etsuro Matsubara, Shigeru Tajima, Tomohiko Takasaki, Yuki Eshita, Takashi Kobayashi. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice. Antiviral Research 2017; 146: 1 doi: 10.1016/j.antiviral.2017.08.007
|
| 30 |
L. Benítez-Gutiérrez, C. de Mendoza, I. Baños, A. Duca, A. Arias, A. Treviño, S. Requena, M.J. Citores, V. Cuervas-Mons. Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir. Transplantation Proceedings 2016; 48(7): 2515 doi: 10.1016/j.transproceed.2016.08.026
|
| 31 |
Xiaobo Zhu, Mingqi Wang, Mei Liu, Xinghao Yu, Peng Huang. Efficacy and Safety of Direct-Acting Antivirals for Treatment-Naive Patients with Genotype 1 Hepatitis C Virus Infection. Personalized Medicine 2019; 16(5): 421 doi: 10.2217/pme-2018-0121
|
| 32 |
Arshia Alimohammadi, Julie Holeksa, Astou Thiam, David Truong, Brian Conway. Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting. Open Forum Infectious Diseases 2018; 5(6) doi: 10.1093/ofid/ofy120
|
| 33 |
Helen Caldwell. Preventing, identifying and treating hepatitis C. Nursing Standard 2019; 34(1): 68 doi: 10.7748/ns.2018.e11321
|
| 34 |
Meera Tandan, Shane Dunlea, Gerard Bury. Hepatitis C Infection and Treatment among Injecting Drug Users Attending General Practice: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 2023; 20(8): 5569 doi: 10.3390/ijerph20085569
|
| 35 |
John C. Christenson, John J. Manaloor. Hepatitis A, B, and C. Pediatrics In Review 2016; 37(10): 426 doi: 10.1542/pir.2015-0075
|
| 36 |
P Abraham. Treatment for hepatitis C virus infection in India: Promising times. Indian Journal of Medical Microbiology 2016; 34(3): 273 doi: 10.4103/0255-0857.188312
|
| 37 |
Krupa Patel, Susan L. Zickmund, Harleigh Jones, Andrea Reid, Linda Calgaro, Arielle Otero, Tami Coppler, Shari S. Rogal. Determinants of Hepatitis C Treatment Adherence and Treatment Completion Among Veterans in the Direct Acting Antiviral Era. Digestive Diseases and Sciences 2019; 64(10): 3001 doi: 10.1007/s10620-019-05590-x
|
| 38 |
Paul G. Carty, Christopher G. Fawsitt, Paddy Gillespie, Patricia Harrington, Michelle O’Neill, Susan M. Smith, Conor Teljeur, Mairin Ryan. Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations. Applied Health Economics and Health Policy 2022; 20(2): 171 doi: 10.1007/s40258-021-00694-w
|
| 39 |
Alejandro Pérez-Pitarch, Beatriz Guglieri-López, Rafael Ferriols-Lisart, Matilde Merino-Sanjuán. A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients. International Journal of Antimicrobial Agents 2016; 47(3): 184 doi: 10.1016/j.ijantimicag.2015.12.008
|
| 40 |
H. Wedemeyer, A. Craxí, E. Zuckerman, D. Dieterich, R. Flisiak, S. K. Roberts, A. Pangerl, Z. Zhang, M. Martinez, Y. Bao, J.‐L. Calleja. Real‐world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta‐analysis. Journal of Viral Hepatitis 2017; 24(11): 936 doi: 10.1111/jvh.12722
|
| 41 |
Salamat Ali, Tofeeq Ur-Rehman, Mashhood Ali, Sayeed Haque, Faisal Rasheed, Eleri Lougher, Muhammad Sarfraz Nawaz, Vibhu Paudyal. Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme. International Journal of Clinical Pharmacy 2021; 43(4): 958 doi: 10.1007/s11096-020-01202-1
|
| 42 |
Miranda S. Moore, Angelica Bocour, Lizeyka Jordan, Emily McGibbon, Jay K. Varma, Ann Winters, Fabienne Laraque. Development and Validation of Surveillance-Based Algorithms to Estimate Hepatitis C Treatment and Cure in New York City. Journal of Public Health Management and Practice 2018; 24(6): 526 doi: 10.1097/PHH.0000000000000688
|
| 43 |
Peng Huang, Yan Wang, Ming Yue, Zhijun Ge, Xueshan Xia, Andre J. Jeyarajan, Jacinta A. Holmes, Rongbin Yu, Chuanwu Zhu, Sheng Yang, Wenyu Lin, Raymond T. Chung. The risk of hepatitis C virus recurrence in hepatitis C virus‐infected patients treated with direct‐acting antivirals after achieving a sustained virological response: A comprehensive analysis. Liver International 2021; 41(10): 2341 doi: 10.1111/liv.14976
|
| 44 |
Tu M. Pham, Si C. Tran, Yun-Sook Lim, Soon B. Hwang, J.-H. James Ou. Hepatitis C Virus-Induced Rab32 Aggregation and Its Implications for Virion Assembly. Journal of Virology 2017; 91(3) doi: 10.1128/JVI.01662-16
|
| 45 |
Sumaiah J. Alarfaj, Abdullah Alzahrani, Anfal Alotaibi, Malak Almutairi, Mashael Hakami, Njood Alhomaid, Noori Alharthi, Ghazwa B. Korayem, Abdullah Alghamdi. The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia. Saudi Pharmaceutical Journal 2022; 30(10): 1448 doi: 10.1016/j.jsps.2022.07.005
|